A new furoxan NO-donor rabeprazole derivative and related compounds

被引：19
|
作者：
Sorba, G
Galli, U
Cena, C
Fruttero, R
Gasco, A
Morini, G
Adami, M
Coruzzi, G
Brenciaglia, MI
Dubini, F
机构：
[1] Univ Turin, Dipartimento Sci & Tecnol Farmaco, I-10125 Turin, Italy
[2] Univ Piemonte Orientale, Dipartimento Sci Chim Alimentari Farmaceut & Farm, I-28100 Novara, Italy
[3] Univ Parma, Dipartimento anat Umana Farmacol & Sci Med Forens, I-43100 Parma, Italy
[4] Univ Roma La Sapienza, Dipartimento Sci & Sanita Pubbl G Sanarelli, I-00186 Rome, Italy
[5] Univ Milan, Ist Microbiol, I-20133 Milan, Italy
来源：
CHEMBIOCHEM | 2003年 / 4卷 / 09期
关键词：
drug design; furoxans; medicinal chemistry; nitric oxide; rabeprazole;
D O I：
10.1002/cbic.200300617
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：899 / 903
页数：5
相关论文
共 50 条
  • [1] Molecular Hybridization Tools in the Development of Furoxan-Based NO-Donor Prodrugs
    Fershtat, Leonid L.
    Makhova, Nina N.
    CHEMMEDCHEM, 2017, 12 (09) : 622 - 638
  • [2] Novel furoxan NO-donor pemetrexed derivatives: design, synthesis, and preliminary biological evaluation
    Tao Min
    Bixin Yi
    Peng Zhang
    Jun Liu
    Can Zhang
    Huiping Zhou
    Medicinal Chemistry Research, 2009, 18 : 495 - 510
  • [3] Novel furoxan NO-donor pemetrexed derivatives: design, synthesis, and preliminary biological evaluation
    Min, Tao
    Yi, Bixin
    Zhang, Peng
    Liu, Jun
    Zhang, Can
    Zhou, Huiping
    MEDICINAL CHEMISTRY RESEARCH, 2009, 18 (07) : 495 - 510
  • [4] Use of the furoxan (1,2,5-oxadiazole 2-oxide) system in the design of new NO-donor antioxidant hybrids
    Cena, Clara
    Bertinaria, Massimo
    Boschi, Donatella
    Giorgis, Marta
    Gasco, Alberto
    ARKIVOC, 2006, : 301 - 309
  • [5] NEW NO-DONOR WITH FUROXAN STRUCTURE CAS-1609 SHOWS NO TOLERANCE DURING CONTINUOUS LONG-TERM APPLICATION IN DOGS
    BASSENGE, E
    FINK, B
    FASEB JOURNAL, 1995, 9 (04): : A923 - A923
  • [6] Synthesis and anti-Helicobacter pylori properties of NO-donor/metronidazole hybrids and related compounds
    Bertinaria, M
    Galli, U
    Sorba, G
    Fruttero, R
    Gasco, A
    Brenciaglia, MI
    Scaltrito, MM
    Dubini, F
    DRUG DEVELOPMENT RESEARCH, 2003, 60 (03) : 225 - 239
  • [7] Recent Developments in Drug Design of NO-donor Hybrid Compounds
    Sharma, Rajan
    Joubert, Jacques
    Malan, Sarel F.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2018, 18 (14) : 1175 - 1198
  • [8] Nicorandil analogues containing NO-donor furoxans and related furazans
    Boschi, D
    Cena, C
    Di Stilo, A
    Fruttero, R
    Gasco, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (07) : 1727 - 1732
  • [9] New potential uroselective NO-Donor α1-antagonists
    Boschi, D
    Tron, GC
    Di Stilo, A
    Fruttero, R
    Gasco, A
    Poggesi, E
    Motta, G
    Leonardi, A
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (17) : 3762 - 3765
  • [10] Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans
    Lazzarato, Loretta
    Cena, Clara
    Rolando, Barbara
    Marini, Elisabetta
    Lolli, Marco Lucio
    Guglielmo, Stefano
    Guaita, Elena
    Morini, Giuseppina
    Coruzzi, Gabriella
    Fruttero, Roberta
    Gasco, Alberto
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (19) : 5852 - 5860
12345